WINTON GROUP Ltd - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$377,970
-32.7%
87,493
+2.7%
0.03%
-34.0%
Q2 2023$561,468
+25.5%
85,200
+29.3%
0.05%
+74.1%
Q1 2023$447,251
-14.7%
65,869
-7.2%
0.03%
-22.9%
Q4 2022$524,409
-0.5%
70,962
+32.9%
0.04%
+2.9%
Q3 2022$527,000
-37.3%
53,377
-30.8%
0.03%
-24.4%
Q2 2022$841,000
-3.6%
77,182
+0.1%
0.04%
-2.2%
Q1 2022$872,000
-2.6%
77,123
+35.3%
0.05%
-14.8%
Q4 2021$895,000
-25.7%
57,022
-18.9%
0.05%
-20.6%
Q3 2021$1,205,000
-31.3%
70,292
-13.8%
0.07%
-27.7%
Q2 2021$1,755,000
+30.0%
81,578
-9.3%
0.09%
+22.1%
Q1 2021$1,350,000
+3.8%
89,907
-9.1%
0.08%
-18.1%
Q4 2020$1,300,000
-51.5%
98,957
-64.3%
0.09%
+8.0%
Q3 2020$2,678,000
-60.0%
277,201
-52.6%
0.09%
-49.7%
Q2 2020$6,695,000
+14.7%
585,248
+3.9%
0.17%
+12.3%
Q1 2020$5,838,000
-35.6%
563,523
+2.0%
0.15%
+21.3%
Q4 2019$9,069,000
+2873.4%
552,640
+2307.6%
0.13%
+3075.0%
Q3 2019$305,00022,9540.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders